| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Jeremy R A Paull | |
| Tom D McCarthy | |||
| Peter Karellas | |||
| Scott A Henderson | |||
| George Holan | |||
| Barry R Matthews | |||
| David F O'Keefe | |||
| Graham Heery | |||
| Michael Giannis | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prevention | Q1717246 |
| prevention of HIV/AIDS | Q7242372 | ||
| P304 | page(s) | 312-318 | |
| P577 | publication date | 2005-07-01 | |
| P1433 | published in | Molecular Pharmaceutics | Q3011140 |
| P1476 | title | Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention | |
| P478 | volume | 2 |
| Q39152233 | "Fusion and binding inhibition" key target for HIV-1 treatment and pre-exposure prophylaxis: targets, drug delivery and nanotechnology approaches. |
| Q94512129 | A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis |
| Q37187788 | A randomized controlled trial of the safety of candidate microbicide SPL7013 gel when applied to the penis |
| Q30431343 | A review of nanotechnological approaches for the prophylaxis of HIV/AIDS. |
| Q38864932 | Aminolevulinic acid dendrimers in photodynamic treatment of cancer and atheromatous disease |
| Q37208310 | An Electrochemical DNA Biosensor Developed on a Nanocomposite Platform of Gold and Poly(propyleneimine) Dendrimer |
| Q57380327 | Applications of Dendrimers in Drug Delivery Agents, Diagnosis, Therapy, and Detection |
| Q38722141 | Bioactive clusters promoting cell penetration and nucleic acid complexation for drug and gene delivery applications: from designed to self-assembled and responsive systems. |
| Q36988348 | Biodegradable, polymeric nanoparticle delivery systems for cancer therapy |
| Q30356032 | Candidate polyanion microbicides inhibit HIV-1 infection and dissemination pathways in human cervical explants. |
| Q30355939 | Clinical Translation of Nanomedicine. |
| Q36803970 | Comparative evaluation of virus transmission inhibition by dual-acting pyrimidinedione microbicides using the microbicide transmission and sterilization assay |
| Q33367952 | Complex Amphiphilic Hyperbranched Fluoropolymers by Atom Transfer Radical Self-Condensing Vinyl (Co)polymerization |
| Q37368022 | Crucial functionalizations of carbon nanotubes for improved drug delivery: a valuable option? |
| Q37984498 | Current and future microbicide approaches aimed at preventing HIV infection in women. |
| Q47352518 | Dendrimer-induced leukocyte procoagulant activity depends on particle size and surface charge |
| Q38755622 | Dendrimer-mediated approaches for the treatment of brain tumor. |
| Q57079901 | Dendrimeric based microbicides against sexual transmitted infections associated to heparan sulfate |
| Q55563721 | Dendrimeric systems and their applications in ocular drug delivery. |
| Q38123954 | Dendrimers as potential therapeutic tools in HIV inhibition. |
| Q37585659 | Dendrimers as therapeutic agents: a systematic review. |
| Q57079961 | Dendrimers as topical microbicides with activity against HIV |
| Q37279284 | Dendrimers for enhanced drug solubilization. |
| Q38196447 | Dendrimers for gene delivery--a potential approach for ocular therapy? |
| Q38542021 | Dendrimers for theranostic applications |
| Q26782404 | Designing Dendrimer and Miktoarm Polymer Based Multi-Tasking Nanocarriers for Efficient Medical Therapy |
| Q37823446 | Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations |
| Q36593791 | Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides. |
| Q37809880 | Drug delivery using multifunctional dendrimers and hyperbranched polymers |
| Q33819656 | Emerging nanotechnology approaches for HIV/AIDS treatment and prevention |
| Q33613788 | Evaluation of WLBU2 peptide and 3-O-octyl-sn-glycerol lipid as active ingredients for a topical microbicide formulation targeting Chlamydia trachomatis |
| Q58869727 | Evaluation of a new dendrimeric structure as prospective drugs carrier for intravenous administration of antichagasic active compounds |
| Q39885075 | Evaluation of the synthesis of sialic acid-PAMAM glycodendrimers without the use of sugar protecting groups, and the anti-HIV-1 properties of these compounds |
| Q37374013 | Formulating a sulfonated antiviral dendrimer in a vaginal microbicidal gel having dual mechanisms of action |
| Q49963085 | Function Oriented Molecular Design: Dendrimers as Novel Antimicrobials |
| Q56992437 | Harnessing nanostructured systems for improved treatment and prevention of HIV disease |
| Q40050425 | Hyperbranched molecular structures with potential antiviral activity: derivatives of 5,6-dihydroxyindole-2-carboxylic Acid. |
| Q38244010 | In vivo studies of nanostructure-based photosensitizers for photodynamic cancer therapy |
| Q39541397 | Inhibition of herpes simplex virus type 1 and type 2 infections by peptide-derivatized dendrimers |
| Q38758579 | Inorganic dendrimers: recent advances for catalysis, nanomaterials, and nanomedicine |
| Q33557251 | Interactions and encapsulation of vitamins C, B3, and B6 with dendrimers in water |
| Q38925952 | Mechanistic Studies of Viral Entry: An Overview of Dendrimer-Based Microbicides As Entry Inhibitors Against Both HIV and HSV-2 Overlapped Infections. |
| Q38041060 | Multivalency as a chemical organization and action principle |
| Q34234274 | Nanodevices in diagnostics. |
| Q27022253 | Nanomedicine approaches for corneal diseases |
| Q34079533 | Nanoparticle-based drug delivery to the vagina: a review |
| Q26795444 | Nanoparticles as potential new generation broad spectrum antimicrobial agents |
| Q34655287 | Nanoparticles in medicine: therapeutic applications and developments |
| Q38250517 | Nanoparticulate carriers: an emerging tool for breast cancer therapy |
| Q26801513 | Nanostructures for the Inhibition of Viral Infections |
| Q30393980 | Nanotechnology and HIV: potential applications for treatment and prevention |
| Q38289100 | New Modalities for Challenging Targets in Drug Discovery |
| Q44460619 | New surface hydroxylated and internally quaternised poly(propylene imine) dendrimers as efficient biocompatible drug carriers of norfloxacin |
| Q35345283 | Non-specific microbicide product development: then and now |
| Q36307689 | One-component nanomedicine |
| Q33270151 | PAMAM dendrimers and branched polyethyleneglycol (nanoparticles) prodrugs of (-)-beta-D-(2R, 4R)-dioxolane-thymine (DOT) and their anti-HIV activity |
| Q33740696 | Peptide and glycopeptide dendrimers and analogous dendrimeric structures and their biomedical applications. |
| Q57815884 | Peptide dendrimers as "lead compounds" for the treatment of chronic lung infections by in cystic fibrosis patients: in vitro and in vivo studies |
| Q38079780 | Peptide inhibitors against herpes simplex virus infections. |
| Q35014689 | Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histocultures |
| Q37657468 | Pharmaceutical development of microbicide drug products |
| Q35012567 | Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004) |
| Q90439921 | Polymer-drug conjugate therapeutics: advances, insights and prospects |
| Q38245819 | Polymeric anti-HIV therapeutics |
| Q37975554 | Polypeptides and polyaminoacids in drug delivery |
| Q36310717 | Polyvalent side chain peptide-synthetic polymer conjugates as HIV-1 entry inhibitors |
| Q34648571 | Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model |
| Q30395011 | Progress in antiretroviral drug delivery using nanotechnology |
| Q38574172 | Protein/peptide-based entry/fusion inhibitors as anti-HIV therapies: challenges and future direction |
| Q38501503 | Recent advances in click chemistry applied to dendrimer synthesis. |
| Q28740364 | SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans |
| Q28749596 | Structure activity relationship of dendrimer microbicides with dual action antiviral activity |
| Q57079929 | Synthesis of anionic carbosilane dendrimers via “click chemistry” and their antiviral properties against HIV |
| Q37354233 | Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders |
| Q40017027 | The Pharmacokinetics and Biodistribution of a 64 kDa PolyPEG Star Polymer After Subcutaneous and Pulmonary Administration to Rats |
| Q28087336 | The potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trials |
| Q41339468 | Triple combination of carbosilane dendrimers, tenofovir and maraviroc as potential microbicide to prevent HIV-1 sexual transmission |
| Q37171165 | Tumour and dendrimers: a review on drug delivery aspects. |
| Q57340548 | Unexpected Biological Applications of Dendrimers and Specific Multivalency Activities |
| Q37059892 | VivaGel (SPL7013 Gel): a candidate dendrimer--microbicide for the prevention of HIV and HSV infection |
Search more.